公开(公告)号：US11857593B2

公开(公告)日：2024-01-02

申请号：US16527001

申请日：2019-07-30

申请人： 4Life Patents, LLC

发明人： Brent M. Vaughan ,  Calvin W. McCausland ,  David A. Lisonbee

IPC分类号： A61K36/889 ,  A23G4/12 ,  A61K36/185 ,  A61K36/35 ,  A61K36/87 ,  A23L29/231 ,  A23L29/238 ,  A23L29/269 ,  A23L29/281 ,  A23L33/10 ,  A23L33/105 ,  A61K47/36

CPC分类号： A61K36/889 ,  A23G4/12 ,  A23L29/231 ,  A23L29/238 ,  A23L29/27 ,  A23L29/271 ,  A23L29/284 ,  A23L33/10 ,  A23L33/105 ,  A61K36/185 ,  A61K36/35 ,  A61K36/87 ,  A61K47/36 ,  A23V2002/00 ,  A23V2200/324 ,  A23V2250/21 ,  A23V2250/21166 ,  A23V2250/506 ,  A23V2250/5086 ,  A23V2250/708 ,  A61K2300/00 ,  A61K36/185 ,  A61K2300/00 ,  A61K36/35 ,  A61K2300/00 ,  A61K36/87 ,  A61K2300/00 ,  A23V2002/00 ,  A23V2200/324 ,  A23V2250/21166 ,  A23V2250/21 ,  A23V2250/708 ,  A23V2250/5086 ,  A23V2250/506

摘要： A nutraceutical food product includes a solid matrix and a liquid combined into a gel. The nutraceutical food product may include an immune modulator, such as transfer factor and/or a nanofraction immune modulator. A fruit component may be included in the nutraceutical food product. The fruit component may include at least one oligoproanthocyanidin-containing fruit, such as açai.

公开(公告)号：US20230225384A1

公开(公告)日：2023-07-20

申请号：US17976724

申请日：2022-10-28

申请人： LAMINARIA GROUP AB

发明人： Olov SKÖLD ,  Anna STRÖM ,  Martin AHNOFF

IPC分类号： A23L33/125 ,  A23L2/38 ,  A23L2/52 ,  A23L29/231 ,  A23L29/256 ,  A23L29/30 ,  A23L33/10 ,  A23L33/175 ,  A23L33/105 ,  A23L33/16 ,  A23L33/15

CPC分类号： A23L33/125 ,  A23L2/38 ,  A23L2/52 ,  A23L29/231 ,  A23L29/256 ,  A23L29/30 ,  A23L33/10 ,  A23L33/175 ,  A23L33/105 ,  A23L33/16 ,  A23L33/15 ,  A23V2002/00 ,  A23V2200/33 ,  A23V2250/06 ,  A23V2250/16 ,  A23V2250/161 ,  A23V2250/1614 ,  A23V2250/1642 ,  A23V2250/21 ,  A23V2250/5026 ,  A23V2250/50722 ,  A23V2250/5114 ,  A23V2250/5118 ,  A23V2250/606 ,  A23V2250/61 ,  A23V2250/62 ,  A23V2250/628 ,  A23V2250/708

摘要： The present invention provides nutritional supplements comprising alginate, in combination with pectin, which will form hydrogels in the stomach when exposed to the low pH of the gastric juice. The formation of a hydrogel will lead to delayed release of sugars and other active ingredients in the stomach. The nutritional supplements can comprise high concentrations of sugars and complex carbohydrates without causing unwanted gastrointestinal symptoms.

公开(公告)号：US20190230971A1

公开(公告)日：2019-08-01

申请号：US16381336

申请日：2019-04-11

申请人： Recommended by Mom LLC

发明人： Jesus Leal

IPC分类号： A23L33/00 ,  A61K31/10 ,  A23L33/10 ,  A61K9/00 ,  B65D51/28 ,  A23L33/15 ,  B65D41/04 ,  A61P43/00 ,  A23L33/155 ,  A23L33/175 ,  A23L23/00 ,  A23L5/44

CPC分类号： A23L33/40 ,  A23L5/44 ,  A23L23/00 ,  A23L33/10 ,  A23L33/15 ,  A23L33/155 ,  A23L33/175 ,  A23V2002/00 ,  A23V2250/0634 ,  A23V2250/211 ,  A23V2250/708 ,  A61K9/0095 ,  A61K31/10 ,  A61P43/00 ,  B65D41/04 ,  B65D51/2864

摘要： A composition for improving the health of a subject in a manner comparable to a bowl of homemade chicken soup is provided. The composition may include n-acetyl cysteine, vitamin C, and one or more carotenoids. The composition may be designed for oral consumption in a variety of dosage forms. The composition may be delivered utilizing a portable all-in-one delivery system. The delivery system may include an interconnected two piece bottle cap that together define a storage chamber that may hold the composition, and a bottle with a solvent connected to the interconnected two-piece bottle cap. The interconnected two-piece bottle cap may be in a locked or in an open state. The composition may be released into the solvent when the two-piece bottle cap interconnection is in the open state. The two-piece bottle cap may further include a delivery mechanism that switches the two-piece bottle cap interconnection from the closed state to the open state.

公开(公告)号：US20180303144A1

公开(公告)日：2018-10-25

申请号：US15770444

申请日：2016-10-24

申请人： N. V. Nutricia

发明人： Amos ATTALI

IPC分类号： A23L33/12 ,  A23L33/155 ,  A61K31/202 ,  A61K45/06

CPC分类号： A23L33/12 ,  A23L33/10 ,  A23L33/15 ,  A23L33/155 ,  A23V2002/00 ,  A23V2200/30 ,  A23V2250/1626 ,  A23V2250/1876 ,  A23V2250/304 ,  A23V2250/7052 ,  A23V2250/7058 ,  A23V2250/706 ,  A23V2250/708 ,  A23V2250/712 ,  A61K31/202 ,  A61K45/06

摘要： The invention relates to a composition comprising) (i) one or more ω-3 fatty acids selected from the group consisting of DHA, DPA and EPA and (ii) one or more pyrimidine derivatives selected from the group consisting of uridine sources and cytidine sources for use in decreasing or normalizing the phenyl alanine level in the blood of a PKU patient or for use in dietary management of phenylalanine levels in the blood of a PKU patient.

公开(公告)号：US09980939B2

公开(公告)日：2018-05-29

申请号：US14771719

申请日：2014-03-13

申请人： ABBOTT LABORATORIES

发明人： Chron-Si Lai ,  Matthew Kuchan

IPC分类号： A61K31/355 ,  A61K31/202 ,  A61K47/22 ,  A61K9/00 ,  A23L33/12 ,  A23L33/15 ,  A23L33/00

CPC分类号： A61K31/355 ,  A23L33/12 ,  A23L33/15 ,  A23L33/40 ,  A23V2002/00 ,  A61K9/0095 ,  A61K31/202 ,  A61K47/22 ,  A23V2200/322 ,  A23V2250/1862 ,  A23V2250/1868 ,  A23V2250/211 ,  A23V2250/54 ,  A23V2250/708 ,  A23V2250/712

摘要： Disclosed are nutritional compositions generally, and infant formulas specifically, that include a combination of RRR-alpha tocopherol, fat, and protein. The amount of non-RRR alpha tocopherol stereoisomers in the nutritional compositions is limited. Also disclosed are methods of using the compositions to improve cognitive, brain and/or central nervous system development in an individual.

公开(公告)号：US09980506B2

公开(公告)日：2018-05-29

申请号：US13794270

申请日：2013-03-11

申请人： Mead Johnson Nutrition Company

发明人： Dattatreya Banavara ,  John Alvey ,  Juan Gonzalez

IPC分类号： A23C9/14 ,  A23L33/115 ,  A23L33/00 ,  A23L33/12 ,  A23L33/135 ,  A23L33/19

CPC分类号： A23L33/115 ,  A23C9/14 ,  A23L33/12 ,  A23L33/135 ,  A23L33/19 ,  A23L33/40 ,  A23V2002/00 ,  A23V2250/1578 ,  A23V2250/1588 ,  A23V2250/1592 ,  A23V2250/1598 ,  A23V2250/16 ,  A23V2250/161 ,  A23V2250/1612 ,  A23V2250/1614 ,  A23V2250/1618 ,  A23V2250/1642 ,  A23V2250/1842 ,  A23V2250/1866 ,  A23V2250/1868 ,  A23V2250/1876 ,  A23V2250/1882 ,  A23V2250/194 ,  A23V2250/28 ,  A23V2250/304 ,  A23V2250/54252 ,  A23V2250/612 ,  A23V2250/702 ,  A23V2250/7042 ,  A23V2250/7044 ,  A23V2250/7046 ,  A23V2250/7052 ,  A23V2250/7056 ,  A23V2250/706 ,  A23V2250/708 ,  A23V2250/71 ,  A23V2250/712 ,  A23V2250/714 ,  A23V2250/72

摘要： The present disclosure relates to a lipid source for nutritional compositions, comprising an enriched lipid fraction which comprises structured fat globules. The enriched lipid fraction provides fat globules having a desired size and fatty acid composition and may be stabilized by components such as phospholipids, cholesterol, milk-fat globule membrane protein and combinations thereof. Additionally, the disclosure relates to methods of supporting lipid digestion in a pediatric subject by providing a nutritional composition comprising an enriched lipid fraction having structured fat globules that are more accessible to lipases. The chemical composition, size and structure of the fat globules may improve digestion. The disclosed nutritional compositions may provide additive and or/synergistic beneficial health effects.

公开(公告)号：US20170202238A1

公开(公告)日：2017-07-20

申请号：US15475636

申请日：2017-03-31

申请人： James John YIANNIOS

发明人： James John YIANNIOS

IPC分类号： A23G3/36 ,  A23G3/48

CPC分类号： A23G3/368 ,  A23G1/42 ,  A23G3/36 ,  A23G3/364 ,  A23G3/48 ,  A23G3/54 ,  A23L33/10 ,  A23L33/15 ,  A23V2002/00 ,  A23V2200/222 ,  A23V2250/1842 ,  A23V2250/31 ,  A23V2250/5086 ,  A23V2250/708 ,  A23V2250/712

摘要： A method of making dietary supplement compositions includes generating an aqueous phase (A1) having one or more dietary supplement nutrients (DSN1), generating an oil phase (O1), performing a first homogenizing step by mixing A1 and O1 thereby forming A1/O1 composition, performing a second homogenizing step by mixing the A1/O1 composition and the further added DSN2, performing a third homogenizing step by mixing the A1/O1/DSN2 composition and a first flavor (F1), performing a fourth homogenizing step by mixing the A1/O1/DSN2/F1 composition and a gum dispersed with glycerin (GG), and performing a fifth homogenizing step by mixing the A1/O1/DSN2/F1/GG composition and the second flavor (F2) thereby forming dietary composition A1/O1/DSN2/F1/GG/F2. The A1/O1/DSN2/F1/GG/F2 composition is dispersion in which actives are incorporated in liposomal vesicles which may have a barrier coating of a polymer. A method of making gummies includes surrounding A1/O1/DSN2/F1/GG/F2 composition (inner portion) with an outer portion formed of shell syrup.

公开(公告)号：US20170189446A1

公开(公告)日：2017-07-06

申请号：US15260827

申请日：2016-09-09

申请人： Joyce Hendler ,  Guardion Health Sciences, LLC

发明人： Sheldon Hendler

IPC分类号： A61K33/34 ,  A61K47/36 ,  A61K47/24 ,  A61K36/45 ,  A61K31/385 ,  A61K47/26 ,  A61K47/10 ,  A61K47/12 ,  A61K31/355 ,  A61K31/593 ,  A61K31/015 ,  A61K31/353 ,  A61K31/122 ,  A61K9/107 ,  A61K31/51 ,  A61K31/375 ,  A61K33/04 ,  A61K33/06 ,  A61K33/32 ,  A61K33/00 ,  A61K31/198 ,  A61K31/145 ,  A61K31/197 ,  A61K31/525 ,  A61K31/455 ,  A61K31/675 ,  A61K31/555 ,  A61K31/4188 ,  A23L33/105 ,  A23L33/15 ,  A23L33/16 ,  A61K31/047

CPC分类号： A61K33/34 ,  A23L33/105 ,  A23L33/15 ,  A23L33/16 ,  A23V2002/00 ,  A61K9/107 ,  A61K31/015 ,  A61K31/047 ,  A61K31/122 ,  A61K31/145 ,  A61K31/197 ,  A61K31/198 ,  A61K31/353 ,  A61K31/355 ,  A61K31/375 ,  A61K31/385 ,  A61K31/4188 ,  A61K31/455 ,  A61K31/51 ,  A61K31/525 ,  A61K31/555 ,  A61K31/593 ,  A61K31/675 ,  A61K33/00 ,  A61K33/04 ,  A61K33/06 ,  A61K33/30 ,  A61K33/32 ,  A61K36/45 ,  A61K47/10 ,  A61K47/12 ,  A61K47/24 ,  A61K47/26 ,  A61K47/36 ,  A61K2300/00 ,  A23V2250/0612 ,  A23V2250/1578 ,  A23V2250/1586 ,  A23V2250/1588 ,  A23V2250/1608 ,  A23V2250/161 ,  A23V2250/1626 ,  A23V2250/1642 ,  A23V2250/21 ,  A23V2250/21168 ,  A23V2250/704 ,  A23V2250/708 ,  A23V2250/7106 ,  A23V2250/712

摘要： A daily liquid supplement for ocular and body health containing at least one of lutein, zeaxanthin, meso-zeaxanthin and astaxanthin for a human subject for nutritionally supplementing macular pigments is disclosed. The micronized nutrients in a lipid based emulsion are more efficiently absorbed into the bloodstream than conventional supplement formulations resulting in higher serum levels and increased macular pigment.

公开(公告)号：US09629386B2

公开(公告)日：2017-04-25

申请号：US13152574

申请日：2011-06-03

申请人： Shinji Somekawa ,  Tomoyuki Mine ,  Naoki Hayashi

发明人： Shinji Somekawa ,  Tomoyuki Mine ,  Naoki Hayashi

IPC分类号： A23L2/52 ,  A23L2/66 ,  A61K31/198 ,  A61K31/202 ,  A61K31/4172 ,  A61K45/06 ,  A23L33/12 ,  A23L33/15 ,  A23L33/175 ,  A23L33/18 ,  A23L33/185

CPC分类号： A23L2/52 ,  A23L2/66 ,  A23L33/12 ,  A23L33/15 ,  A23L33/175 ,  A23L33/18 ,  A23L33/185 ,  A23V2002/00 ,  A61K31/198 ,  A61K31/202 ,  A61K31/4172 ,  A61K45/06 ,  A61K2300/00 ,  A23V2200/32 ,  A23V2250/5488 ,  A23V2250/06 ,  A23V2250/1944 ,  A23V2250/708 ,  A23V2250/712 ,  A23V2250/1626 ,  A23V2250/1642 ,  A23V2250/1882

摘要： The present invention can provide a nutrition composition useful for patients with renal diseases, which has an effective prophylactic or improving effect for various symptoms of malnutrition, inflammation, arteriosclerosis, abnormal lipid metabolism and oxidative stress, associated with renal diseases, or for diabetic nephropathy.The nutrition composition of the present invention m contains one or more kinds of free amino acids selected from the group consisting of valine, leucine, isoleucine and histidine, and a lipid comprising ω-3 fatty acid and ω-6 fatty acid at a weight ratio (ω-6 fatty acid to ω-3 fatty acid) of 0.5-5.5. In addition, the composition further contains a soybean protein or a hydrolysate thereof together with the aforementioned lipid or instead of the aforementioned lipid.

公开(公告)号：US09579336B2

公开(公告)日：2017-02-28

申请号：US14005098

申请日：2012-03-14

申请人： Mattheus Cornelis De Wilde ,  Johannes Wilhelmus Christina Sijben ,  Patrick Joseph Gerardus Hendrikus Kamphuis ,  Robert Johan Joseph Hageman

发明人： Mattheus Cornelis De Wilde ,  Johannes Wilhelmus Christina Sijben ,  Patrick Joseph Gerardus Hendrikus Kamphuis ,  Robert Johan Joseph Hageman

IPC分类号： A61K31/7072 ,  A61K31/7056 ,  A61K31/14 ,  A61K31/202 ,  A61K31/7068 ,  A61K9/00 ,  A61K31/205 ,  A61K31/355 ,  A61K31/375 ,  A61K31/4415 ,  A61K31/519 ,  A61K31/685 ,  A61K31/714 ,  A23D7/00 ,  A23D7/005

CPC分类号： A61K31/7056 ,  A23D7/003 ,  A23D7/0053 ,  A23L33/115 ,  A23L33/13 ,  A23V2002/00 ,  A61K9/0095 ,  A61K31/14 ,  A61K31/202 ,  A61K31/205 ,  A61K31/355 ,  A61K31/375 ,  A61K31/4415 ,  A61K31/519 ,  A61K31/675 ,  A61K31/685 ,  A61K31/7068 ,  A61K31/7072 ,  A61K31/714 ,  A61K33/04 ,  A61K2300/00 ,  A23V2200/08 ,  A23V2200/322 ,  A23V2250/1626 ,  A23V2250/1868 ,  A23V2250/187 ,  A23V2250/304 ,  A23V2250/7052 ,  A23V2250/7056 ,  A23V2250/706 ,  A23V2250/708 ,  A23V2250/712

摘要： The invention relates to a composition comprising: i) one or more of uridine and cytidine, or salts, phosphates, acyl derivatives or esters thereof; ii) a lipid fraction comprising at least one of docosahexaenoic acid (22:6; DHA), eicosapentaenoic acid (20:5; EPA) and docosapentaenoic acid (22:5; DPA), or esters thereof, in which the lipid fraction comprises less than 2 weight % of □-linolenic acid (ALA), calculated on the weight of all fatty acids; iii) choline, or salts or esters thereof; for use in the prevention or treatment of neurotrauma, traumatic brain injury, cerebral palsy and spinal cord injury.

摘要翻译： 本发明涉及一种组合物，其包含：i）尿苷和胞苷中的一种或多种，​​或其盐，磷酸酯，酰基衍生物或其酯; ii）包含二十二碳六烯酸（22:6; DHA），二十碳五烯酸（20:5; EPA）和二十二碳五烯酸（22：5; DPA）或其酯的至少一种的脂质部分，其中脂质部分包含 小于2重量％的α-亚麻酸（ALA），以所有脂肪酸的重量计算; iii）胆碱或其盐或酯; 用于预防或治疗神经损伤，创伤性脑损伤，脑性麻痹和脊髓损伤。